Sitosterolemia.

2区 医学 Q1 Chemistry
Advances in Clinical Chemistry Pub Date : 2022-01-01 Epub Date: 2022-08-09 DOI:10.1016/bs.acc.2022.06.006
Hayato Tada, Nobuko Kojima, Masayuki Takamura, Masa-Aki Kawashiri
{"title":"Sitosterolemia.","authors":"Hayato Tada,&nbsp;Nobuko Kojima,&nbsp;Masayuki Takamura,&nbsp;Masa-Aki Kawashiri","doi":"10.1016/bs.acc.2022.06.006","DOIUrl":null,"url":null,"abstract":"<p><p>Sitosterolemia is an inherited metabolic disorder characterized by increased levels of plant sterols, such as sitosterol. This disease is caused by loss-of-function genetic mutations in the ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or ABCG8, respectively), both of which play important roles in the selective excretion of plant sterols from the liver and intestine, leading to a failure to excrete plant sterols. Sitosterolemia, which is currently considered a rare genetic disorder, has been described as a phenocopy of homozygous familial hypercholesterolemia (FH). Typical phenotypes of sitosterolemia, including elevated low-density lipoprotein (LDL) cholesterol, tendon xanthomas, and premature coronary artery disease, overlap those of homozygous FH; however, there are substantial differences between these two diseases in terms of treatments and prognoses. Moreover, it is of note that sitosterolemia appears to be quite underdiagnosed, although accurate diagnosis and appropriate interventions will likely to lead to better prognoses compared with homozygous FH. Unlike cases of homozygous FH, dietary counseling is quite effective in reducing the LDL cholesterol as well as sitosterol of patients with sitosterolemia. In this chapter, we summarize the current understandings of this disease and provide useful tips for the diagnosis as well as better treatment of patients with sitosterolemia.</p>","PeriodicalId":50872,"journal":{"name":"Advances in Clinical Chemistry","volume":"110 ","pages":"145-169"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/bs.acc.2022.06.006","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 0

Abstract

Sitosterolemia is an inherited metabolic disorder characterized by increased levels of plant sterols, such as sitosterol. This disease is caused by loss-of-function genetic mutations in the ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or ABCG8, respectively), both of which play important roles in the selective excretion of plant sterols from the liver and intestine, leading to a failure to excrete plant sterols. Sitosterolemia, which is currently considered a rare genetic disorder, has been described as a phenocopy of homozygous familial hypercholesterolemia (FH). Typical phenotypes of sitosterolemia, including elevated low-density lipoprotein (LDL) cholesterol, tendon xanthomas, and premature coronary artery disease, overlap those of homozygous FH; however, there are substantial differences between these two diseases in terms of treatments and prognoses. Moreover, it is of note that sitosterolemia appears to be quite underdiagnosed, although accurate diagnosis and appropriate interventions will likely to lead to better prognoses compared with homozygous FH. Unlike cases of homozygous FH, dietary counseling is quite effective in reducing the LDL cholesterol as well as sitosterol of patients with sitosterolemia. In this chapter, we summarize the current understandings of this disease and provide useful tips for the diagnosis as well as better treatment of patients with sitosterolemia.

血清素缺乏症。
谷甾醇血症是一种遗传性代谢紊乱,其特征是植物固醇(如谷甾醇)水平升高。这种疾病是由atp结合盒(ABC)亚家族G成员5或8(分别为ABCG5或ABCG8)的功能丧失基因突变引起的,这两个基因在肝脏和肠道选择性排泄植物甾醇中起重要作用,导致植物甾醇排泄失败。谷甾醇血症,目前被认为是一种罕见的遗传疾病,已被描述为纯合子家族性高胆固醇血症(FH)的表型。谷固醇血症的典型表型,包括低密度脂蛋白(LDL)胆固醇升高、肌腱黄瘤和过早冠状动脉疾病,与纯合子FH的表型重叠;然而,这两种疾病在治疗和预后方面存在实质性差异。此外,值得注意的是,尽管与纯合子FH相比,准确的诊断和适当的干预可能会导致更好的预后,但谷甾醇血症似乎未得到充分诊断。与纯合子FH不同,饮食咨询在降低低密度脂蛋白胆固醇和谷甾醇血症患者的谷甾醇方面非常有效。在本章中,我们总结了目前对这种疾病的认识,并为谷固醇血症患者的诊断和更好的治疗提供了有用的提示。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Clinical Chemistry
Advances in Clinical Chemistry 医学-医学实验技术
CiteScore
10.60
自引率
0.00%
发文量
53
审稿时长
>12 weeks
期刊介绍: Advances in Clinical Chemistry volumes contain material by leading experts in academia and clinical laboratory science. The reviews cover a wide variety of clinical chemistry disciplines including clinical biomarker exploration, cutting edge microarray technology, proteomics and genomics. It is an indispensable resource and practical guide for practitioners of clinical chemistry, molecular diagnostics, pathology, and clinical laboratory sciences in general.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信